|
MGC16142 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.29989999999125E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.960000E-04 |
| Normal-vs-Stage2 |
2.326200E-01 |
| Normal-vs-Stage3 |
9.49409999506656E-08 |
| Normal-vs-Stage4 |
9.05950000018585E-07 |
| Stage1-vs-Stage2 |
1.899970E-01 |
| Stage1-vs-Stage3 |
2.863900E-03 |
| Stage1-vs-Stage4 |
3.678600E-03 |
| Stage2-vs-Stage3 |
3.902800E-03 |
| Stage2-vs-Stage4 |
2.003200E-03 |
| Stage3-vs-Stage4 |
4.899800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.49010000003192E-06 |
| Normal-vs-AfricanAmerican |
6.622900E-04 |
| Normal-vs-Asian |
4.463700E-02 |
| Caucasian-vs-AfricanAmerican |
2.718600E-01 |
| Caucasian-vs-Asian |
7.922300E-02 |
| AfricanAmerican-vs-Asian |
4.039500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.035550E-04 |
| Normal-vs-Female |
5.83549999999544E-05 |
| Male-vs-Female |
5.113400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.283240E-03 |
| Normal-vs-Age(41-60Yrs) |
5.76609999999311E-05 |
| Normal-vs-Age(61-80Yrs) |
1.038750E-04 |
| Normal-vs-Age(81-100Yrs) |
9.002300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.552400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.892810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.690650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.465200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.480200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.973400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.019000E-03 |
| Classical-VS-Follicular |
9.722200E-02 |
| Classical-VS-Other |
3.188800E-01 |
| Classical-VS-Normal |
1.7073899999942E-05 |
| Tall-VS-Follicular |
5.022700E-04 |
| Tall-VS-Other |
1.159440E-01 |
| Tall-VS-Normal |
1.42280000003936E-07 |
| Follicular-VS-Other |
3.184200E-01 |
| Follicular-VS-Normal |
1.708270E-02 |
| Other-VS-Normal |
9.665000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.176400E-03 |
| Normal-vs-N1 |
1.710399999999E-05 |
| N0-vs-N1 |
1.388430E-02 |
|
|
